Delivery Order SPE2DB22D2007-SPE2DB24FJ5JG

Award Date 8/22/24
Potential Completion Date 9/13/24
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,038.00 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 400 MG VIALS. The award has an ultimate completion date of October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range...
This is a $2,606.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 400 mg vials of the drug BENLYSTA. The contract has an ultimate completion date of January 22, 2025 and was awarded on December 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a $7,557 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Benlysta 400 mg vials. The contract has an ultimate completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a $2,275.20 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 120 mg vials of Benlysta, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs. The contract has an...
This is a $7,557 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 400 mg vials of the prescription drug BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies from AmerisourceBergen to...
The U.S. Defense Logistics Agency (DLA) awarded a $7,557 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 400 mg vials of the pharmaceutical product BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to military treatment programs and facilities...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical services company Amerisourcebergen Corporation. The contract is for the delivery of 400 mg vials of the drug BENLYSTA, with a potential value of $7,557.00 and a completion date of March 25, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
This is a $7,557.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a...
The U.S. Defense Logistics Agency (DLA) awarded a $5,688 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 120 mg vials of the specialty medication BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs. The contract...
This contract is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Amerisourcebergen Corporation. The $1,259.50 firm fixed price award is for the supply of 400 mg vials of the specialty medication BENLYSTA, with a completion date of March 5, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing, single-award indefinite delivery contract (IDC) with DLA, which has a potential value...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ5JG
    Delivery Order

This is a $7,557.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for 400mg vials of the pharmaceutical product BENLYSTA. The delivery order was awarded on August 22, 2024 with an ultimate completion date of September 13, 2024.

The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.

Generated 11/21/24, 9:29 AM